Elevation Oncology, Inc.

Elevation Oncology, Inc. (ELEV) priced its initial public offering on Jun 25, 2021 at $16.00 per share, within its $15.00–$17.00 range, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $365.2M. J.P. Morgan was lead-left underwriter, joined by TD Cowen, Leerink Partners and Wedbush.

Status

IPO

Ticker

ELEV

Exchange

Nasdaq Global Select

Priced

Jun 25, 2021

IPO price

$16.00

Price range

$15.00–$17.00

Market cap at IPO price

$365.2M

First filed

Jun 4, 2021

Underwriters

J.P. Morgan, TD Cowen, Leerink Partners and Wedbush

Sector

Biotech & pharma

Country / state

MA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.